The effect of 6 months migalastat treatment on podocyte globotriaosylceramide inclusion content, independent of mosaicism, in females with Fabry disease and amenable GLA mutations
|Effective start/end date||6/5/18 → 6/4/19|
- University of Washington
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.